Position
Chief Financial Officer
Company
Kyverna Therapeutics
EmeryvilleBiotechnologyHealth CareScience And EngineeringDescription
Kyverna Therapeutics, Inc has announced the appointment of Dr Marc Grasso as its Chief Financial Officer, effective today. Dr Grasso brings over 25 years of experience in public companies and capital markets.
Quick answer
Kyverna Therapeutics Appoints Marc Grasso as Chief Financial Officer (June 30, 2025). Kyverna Therapeutics is based in Emeryville, California, United States.
- Who is the new Chief Financial Officer at Kyverna Therapeutics?
- Kyverna Therapeutics named Marc Grasso Chief Financial Officer, announced June 30, 2025.
- What did Kyverna Therapeutics announce on June 30, 2025?
- Kyverna Therapeutics, Inc has announced the appointment of Dr Marc Grasso as its Chief Financial Officer, effective today. Dr Grasso brings over 25 years of experience in public companies and capital markets.
- What does Kyverna Therapeutics do?
- Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
- Where is Kyverna Therapeutics based?
- Kyverna Therapeutics is based in Emeryville, California, United States.
- Which similar companies made leadership changes around the same time?
- Cardiff Oncology (June 17, 2025), Unlearn (July 29, 2025), Upstream Bio (May 20, 2025) and Jade Biosciences (July 1, 2025) also announced leadership changes within 45 days of Kyverna Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer (June 17, 2025)
- Unlearn Appoints Kwame Marfo as Vice President of Product (July 29, 2025)
- Upstream Bio Appoints Stacy Price as Chief Technology Officer (May 20, 2025)
- Jade Biosciences Appoints Brad Dahms as Chief Financial Officer (July 1, 2025)
- Vesper Bio Appoints Jacob Falck Hansen as Chief Executive Officer (July 1, 2025)
- Lavior Pharma Inc. Appoints Dr. Imaze Marian Davis as Chief Medical Officer (July 1, 2025)
Who to call at Kyverna Therapeutics, and when
A new leader at Kyverna Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Kyverna Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kyverna Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kyverna Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kyverna Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kyverna Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.